Gastrointestinal angiodysplasia and bleeding in von Willebrand disease

被引:50
作者
Franchini, Massimo [1 ]
Mannucci, Pier Mannuccio [2 ]
机构
[1] Carlo Poma Hosp, Dept Transfus Med & Hematol, Mantua, Italy
[2] IRCCS Ca Granda Fdn Maggiore Hosp, Sci Direct, Milan, Italy
关键词
von Willebrand disease; bleeding; gastrointestinal angiodysplasia; therapy; PROPHYLAXIS; MANAGEMENT; HEMOSTASIS; PATIENT; SAFETY;
D O I
10.1160/TH13-11-0952
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Von Willebrand disease (VWD), the most common genetic bleeding disorder, is characterised by a quantitative or qualitative defect of von Willebrand factor (VWF). Patients with VWD suffer from mucocutaneous bleeding, of severity usually proportional to the degree of VWF defect. In particular, gastrointestinal bleeding associated with angiodysplasia is often a severe symptom of difficult management. This review focuses on the pathophysiology, diagnosis and treatment of VWD-associated gastrointestinal angiodysplasia and related bleeding.
引用
收藏
页码:427 / 431
页数:5
相关论文
共 49 条
[1]   Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN) [J].
Abshire, T. C. ;
Federici, A. B. ;
Alvarez, M. T. ;
Bowen, J. ;
Carcao, M. D. ;
Gill, J. Cox ;
Key, N. S. ;
Kouides, P. A. ;
Kurnik, K. ;
Lail, A. E. ;
Leebeek, F. W. G. ;
Makris, M. ;
Mannucci, P. M. ;
Winikoff, R. ;
Berntorp, E. .
HAEMOPHILIA, 2013, 19 (01) :76-81
[3]   Von Willebrand disease, angiodysplasia and atorvastatin [J].
Alikhan, Raza ;
Keeling, David .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (01) :159-160
[4]   Long-term prophylaxis in von Willebrand disease [J].
Berntorp, E ;
Petrini, P .
BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 :S23-S26
[5]   Treatment and prevention of acute bleedings in von Willebrand disease - efficacy and safety of Wilate®, a new generation von Willebrand factor/factor VIII concentrate [J].
Berntorp, E. ;
Windyga, J. .
HAEMOPHILIA, 2009, 15 (01) :122-130
[6]  
Boneu B, 1987, Transfus Med Rev, V1, P182
[7]   Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease [J].
Bowers, M ;
McNulty, O ;
Mayne, E .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (03) :524-527
[8]   Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients [J].
Castaman, G. ;
Federici, A. B. ;
Tosetto, A. ;
La Marca, S. ;
Stufano, F. ;
Mannucci, P. M. ;
Rodeghiero, F. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (04) :632-638
[9]  
CASTILLO R, 1991, BLOOD, V77, P1901
[10]   ANGIODYSPLASIA AND VONWILLEBRANDS DISEASE TYPE-IIB TREATED WITH ESTROGEN PROGESTERONE THERAPY [J].
CHEY, WD ;
HASLER, WL ;
BOCKENSTEDT, PL .
AMERICAN JOURNAL OF HEMATOLOGY, 1992, 41 (04) :276-279